Bildkälla: Stockfoto

Moberg Pharma: Adding growth Capital - Redeye

Redeye comments on this morning’s fully guaranteed rights issue. Factoring in this issue and additional cash, we adjust our Base case to SEK 8 per share.

Redeye comments on this morning’s fully guaranteed rights issue. Factoring in this issue and additional cash, we adjust our Base case to SEK 8 per share.
Börsvärldens nyhetsbrev
ANNONSER